Last update 13 Jan 2026

Gemigliptin L-tartrate Sesquihydrate/Dapagliflozin/Metformin Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
DPP-4 x PRKAB1 x SGLT2
Action
inhibitors, activators
Mechanism
DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors), PRKAB1 activators(Protein kinase AMP-activated non-catalytic subunit beta 1 activators), SGLT2 inhibitors(Sodium/glucose cotransporter 2 inhibitors)
Therapeutic Areas-
Active Indication-
Inactive Indication-
Originator Organization
LG Chem Ltd.LG Chem Ltd.
Active Organization
LG Chem Ltd.LG Chem Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Gemigliptin L-tartrate Sesquihydrate/Dapagliflozin/Metformin Hydrochloride
NCT07333742
/ CompletedPhase 1
A Randomized, Open Label, Single Oral Dose, 2x2 Crossover Study to Compare the Pharmacokinetics and Safety/Tolerability of Gemigliptin/Dapagliflozin/Metformin 50/10/1000 mg and Coadministration of Gemigliptin 50 mg and Dapagliflozin/Metformin 10/1000 mg in Healthy Adults in Fed Condition
100 Clinical Results associated with Gemigliptin L-tartrate Sesquihydrate/Dapagliflozin/Metformin Hydrochloride
Login to view more data
100 Translational Medicine associated with Gemigliptin L-tartrate Sesquihydrate/Dapagliflozin/Metformin Hydrochloride
Login to view more data
100 Patents (Medical) associated with Gemigliptin L-tartrate Sesquihydrate/Dapagliflozin/Metformin Hydrochloride
Login to view more data
100 Deals associated with Gemigliptin L-tartrate Sesquihydrate/Dapagliflozin/Metformin Hydrochloride
Login to view more data

R&D Status

Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free